ASC Revenue Cycle Management: Denial Rates, Days in AR and the Benchmarks to Hold
ASC owners obsess over case volume, but the real margin gap often hides in the billing office. This episode breaks down the two benchmarks, denial rate and days in accounts receivable, that separate a twelve percent EBITDA margin from a thirty seven percent one.
Chapters:
0:06 Cold Open
1:02 The Setup
1:39 The Two Numbers That Actually Matter
2:29 Why Billing Is Getting Harder, Not Easier
3:39 Where Denials Actually Start
4:53 Management Fees and What You're Actually Buying
5:32 What To Actually Do This Quarter
6:04 Close
Free guide, The 2027 ASC State of the Union: https://sigmatic.ai/guide
Book a free consultation: https://sigmatic.ai/contact
#asc #surgerycenter #ambulatorysurgery #healthcarefinance #orutilization #revenuecycle #medicalbilling
Chapters
- 00:06 Cold Open
- 01:02 The Setup
- 01:39 The Two Numbers That Actually Matter
- 02:29 Why Billing Is Getting Harder, Not Easier
- 03:39 Where Denials Actually Start
- 04:53 Management Fees and What You're Actually Buying
- 05:32 What To Actually Do This Quarter
- 06:04 Close
Transcript
Read the full transcript Every episode is transcribed, searchable, and quotable. Plain text
Sigmatic: Here's a number that should bother you. Centers under three million dollars in revenue post an E B I T D A margin of twelve point eight percent. Centers over nine million dollars post thirty seven point three percent. Same industry. Same basic business of doing surgery and getting paid for it. That gap is not all scheduling or supply costs. A real chunk of it is sitting in your billing office right now, in the form of a denial nobody has reworked yet, or an accounts receivable balance that's quietly aging past ninety days while everyone's too busy to call the payer back. Margin leaves the building through a messy revenue cycle just as easily as it does through an idle operating room. Today I want to talk about the two numbers that actually define whether your revenue cycle is healthy, why collecting is about to get harder, not easier, and what to check this quarter before it shows up on a remittance advice you didn't expect.
Sigmatic: A denial rate under five percent, with one to two percent as the real target if you're running clean. And days in accounts receivable under thirty, with seventy two percent of that balance current, meaning it's not sitting around aging. Most centers do not hit both. And here's the thing nobody says out loud enough. This isn't just a billing department problem. A denial that takes three weeks to rework is margin leaving the building. An A R balance that sits in the ninety day bucket until someone has time is margin leaving the building. It shows up nowhere faster than in your E B I T D A line.
Sigmatic: Let's get specific, because vague benchmarks don't help anyone run a billing meeting. Denial rate is claims denied on first submission, divided by claims sent. Under five percent is the ceiling. And here's the part that changes how you fix it. Most denials trace back to eligibility and authorization problems that started at booking, not mistakes made three weeks later in the billing office. Days in accounts receivable is receivables divided by average daily net revenue, and the benchmark is under thirty days. But S I S found something sneakier here. A center can hit thirty days on average and still have half its A R sitting past due. The average hides a collections problem. You have to measure both the average and the distribution, every single month, the same way, or you're flying with half the instrument panel covered.
Sigmatic: If you think this gets simpler next year, it doesn't. The twenty twenty six Medicare rule added five hundred sixty procedures to the A S C covered list. Two hundred seventy one of those moved off the inpatient only list, plus thirty five ancillary services. Every one of those is a billing problem before it's a revenue opportunity. A newly covered procedure with no established commercial rate isn't a payment waiting to happen, it's a negotiation your billing office and your administrator need to have before the first case ever gets scheduled. We wrote up the full detail on what changed in that rule and what to confirm before the twenty twenty seven update. I'll put the links in the description. There's also a quality piece tied to the same rule. It ties a two point six percent payment update to the A S C Quality Reporting Program. Centers that don't meet those reporting requirements don't just miss the increase, they lose two percentage points off their update. That's a billing office responsibility as much as a clinical one. A missed submission costs you the whole year's update, and nobody finds out until the number on the remittance advice comes in lower than expected.
Sigmatic: Here's something that surprises people. A cancellation inside twenty four hours is both a clinical event and a billing event. The slot rarely refills, and the claim never gets filed at all. The same schedule discipline that protects your block utilization and your first case starts is protecting your revenue cycle too. We've got a full rundown of the schedule metrics worth tracking alongside denial rate and A R. The links are in the blog, click over and check them out. There's also a quieter revenue cycle leak worth naming, implant and supply pricing. And then there's the bigger structural shift. Most commercial payers price A S C procedures as a multiple of the Medicare rate, which means every one of those new twenty twenty six procedures needs its own rate conversation, not a blanket percentage applied on autopilot. Medicare itself is moving toward site neutral payment, paying the same rate for the same service no matter where it happens, and hospital outpatient rates are generally still higher than A S C rates for the same procedure today. That gap is your negotiating position. Walking into that conversation with cost per case data, by procedure and by payer, is what separates an owner who improves a contract from one who just signs the renewal as written.
Sigmatic: A lot of centers outsource billing to a management company, and the fee commonly runs four to seven percent of net revenue, on top of an equity stake. That's widely reported across the industry, not something I'm inventing here. The question worth asking isn't whether the fee is fair in the abstract. It's whether it's buying you results. If your denial rate and your days in A R are beating the S I S benchmarks, that fee is doing its job. If your monthly report can't show you either number, broken out the way we just described, you're paying for activity, not outcomes. That's worth raising at your next contract renewal, not after it.
Sigmatic: First, pull your denial rate and days in A R for the last three months, by payer, and hold them against the S I S numbers, under five percent and under thirty days, with seventy two percent current. Second, list every procedure your surgeons plan to add under the twenty twenty six covered list, and mark which payers already have a commercial rate attached versus which ones need a brand new negotiation. Third, confirm your A S C Quality Reporting submission is complete before year end.
Sigmatic: If you want to make your A S C more profitable, book a free consultation with us at sigmatic dot A I. The links are in the show notes. Thanks for spending this time with us on The Margin, we'll see you next episode.
After the episode
Want a more profitable ASC?
Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.
Make your ASC more profitable.
A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.